Ovid Therapeutics is a New York-based company with a focus on developing medicines for patients living with rare neurological disorders. The company partners with patient advocacy groups and foundations in order to better understand the community for whom it is working.It also collaborates with other biotechnology and pharmaceutical companies to develop its therapeutics, such as Takeda and Lundbeck.
The company has multiple therapeutics that are in the process of going through clinical trials. It focuses on specific neurological disorders and develops drugs to treat those disorders. One such disorder is Angelman syndrome. The company is conducting clinical trials for both adolescents and adults for therapeutics such as gaboxadol.
FAnother disorder for which the company is developing therapeutics is Fragile X syndrome. The clinical trials also used the therapeutic gaboxadol. The studies for CDKL5 deficiency disorder and chromosome 15q duplication syndrome used the therapeutic soticlestat to seek results.